Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910606 · ClinicalTrials.gov registry record · NA
Strong Foundations 2.0: A Digitally Delivered Fall Prevention Program.
A NA study of Balance and Fall Prevention, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT05910606: Active NA study of Balance and Fall Prevention, sponsored by University of California, San Diego.
NCT05910606 is a NA study of Balance and Fall Prevention that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 92 participants, below the 102-participant average among 7 other Balance trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05910606, a NA study of Balance and Fall Prevention, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Description: The investigators propose to extend earlier research conducted during a feasibility study (Strong Foundations 1.0) by enrolling participants who have a greater risk for falling (x4 cohorts of up to 15 individuals) and from a lower socio-economic status (x4 cohorts of up to 15 individuals), and by collecting high quality laboratory based measures of balance, posture, and strength to better determine the effectiveness of the program and its suitability for widespread deployment. Additionally, the investigators hope to showcase it is feasible to sustain programmatic gains with ongoing digitally delivered content by combining cohorts into a larger group that continues to practice the foundational exercises taught during the 12-week initial program.
Primary Outcome
Change in composite score and individual scores for all components Summary Score 0-12 with higher values being indicative of better performance. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention. Gait Speed: Measured in m/sec with higher values being indicative of better performance and lower risk Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention 5 repetition cha
Conditions Studied
Interventions
- BEHAVIORAL Digital Exercise
Study Locations (1)
California
- UCSD Health - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05910606 still lists
NCT05910606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 102-participant average among 7 other Balance trials with a reported enrollment target (10% lower).
The record links to 3 conditions, with Balance appearing as the primary indexed condition, and to 1 intervention - of which Digital Exercise is the first listed.
NCT05910606 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05910606 about?
NCT05910606 is a clinical study titled "Strong Foundations 2.0: A Digitally Delivered Fall Prevention Program.". Study Description: The investigators propose to extend earlier research conducted during a feasibility study (Strong Foundations 1.0) by enrolling participants who have a greater risk for falling (x4 cohorts of up to 15 individuals) and from a lower socio-economic status (x4 cohorts of up to 15 indi...
What is the current status of trial NCT05910606?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2023-09-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05910606 study?
This clinical trial studies the following conditions: Balance, Fall Prevention, Bone Health.
What interventions are being tested in trial NCT05910606?
The interventions under investigation include: Digital Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT05910606?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05910606 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Balance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sensor Ankle Brace for Special Operations Rehabilitation
RECRUITING · NA
-
Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking
COMPLETED · NA
-
Spinal Manipulative Therapy: Dual-Task Performance
COMPLETED · NA
-
Intermittent Visual Perturbations to Enhance Balance Training
RECRUITING · Early Phase 1
-
Evaluation of the Ballroom Basics for Balance Program
COMPLETED
-
Postural Effects of Being Rotated in a Whole Body Gyroscope
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI